CHEK1 and cancer: Downregulation of Chk1 by K1586 treatment thus provides a novel approach to inhibiting checkpoint progression in the S phase or at the G2-to-M phase transition (Figure 2C) and to enhancing radiation-induced killing of cancer cells (Figure 4).